Références
Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86(2):515–581
Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6): 610–621
Smith JD, Trogan E, Ginsberg M, et al (1995) Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 92(18):8264–8268
Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47(8 Suppl):C13–C18
Zhou X, Nicoletti A, Elhage R, Hansson GK (2000) Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102(24):2919–2922
Gupta S, Pablo AM, Jiang X, et al (1997) IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99(11): 2752–2761
Maldonado-López R, De Smedt T, Michel P, et al (1999) CD8alpha+ and CD8alpha− subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189(3): 587–592
Davenport P, Tipping PG (2003) The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 163(3):1117–1125
Mallat Z, Corbaz A, Scoazec A, et al (2001) Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 89(7):E41–E45
Mallat Z, Corbaz A, Scoazec A, et al (2001) Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104(14):1598–1603
Heeschen C, Dimmeler S, Hamm CW, et al (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348(12):1104–1111
Binder CJ, Hartvigsen K, Chang MK, et al (2004) IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 114(3):427–437
Mallat Z, Ait-Oufella H, Tedgui A (2007) Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc Med 17(4):113–118
von Boehmer H (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6(4):338–344
Fontenot JD, Rasmussen JP, Williams LM, et al (2005) Regulatory T cell lineage specification by the forkhead transcription factor FOXP3. Immunity 22(3):329–341
Salomon B, Lenschow DJ, Rhee L, et al (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12(4):431–440
Mallat Z, Besnard S, Duriez M, et al (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85(8):e17–e24
Potteaux S, Deleuze V, Merval R, et al (2006) In vivo electrotransfer of interleukin-10 cDNA prevents endothelial upregulation of activated NF-kappaB and adhesion molecules following an atherogenic diet. Eur Cytokine Netw 17(1):13–18
Gojova A, Brun V, Esposito B, et al (2003) Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 102(12):4052–4058
Mallat Z, Gojova A, Brun V, et al (2003) Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108(10):1232–1237
Ait-Oufella H, Salomon BL, Potteaux S, et al (2006) Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12(2):178–180
Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352(25):2598–2608
Steffens S, Burger F, Pelli G, et al (2006) Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 114(18):1977–1984
van Puijvelde GH, Hauer AD, de Vos P, et al (2006) Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 114(18):1968–1976
Kolodgie FD, Narula J, Burke AP, et al (2000) Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 157:1259–1268
Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86:515–581
Mallat Z, Gojova A, Brun V, et al (2003) Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108(10):1232–1237
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ait-Oufella, H., Guidet, B. & Mallat, Z. Implication de l’immunité innée au-delà de la réponse à l’infection — L’athérosclérose: une maladie inflammatoire. Réanimation 20 (Suppl 2), 345–352 (2011). https://doi.org/10.1007/s13546-010-0113-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13546-010-0113-2